More than three-quarters of lupus patients taking obinutuzumab (Gazvya) had a significant improvement in their symptoms after a year on the drug, researchers reported March 6 in The New England ...

It's a sad and inconvenient fact that many drugs have to be administered in the form of a slow intravenous (IV) drip, as opposed to a single quick injection. That may be about to change, however, ...

Patients with some cancers, autoimmune diseases, and metabolic disorders often endure time-consuming intravenous (IV) infusions to receive the best protein-based treatments available. Because these ...

SAN ANTONIO, Texas — Researchers have made a major breakthrough that could transform IV medications into oral treatments for diseases like brain cancer and Alzheimer’s, potentially revolutionizing how ...

Nov 19 (Reuters) - Merck (MRK.N), opens new tab said on Tuesday a study showed its injectable version of cancer drug Keytruda was not inferior to the currently approved intravenous formulation of its ...

It Takes a Village! Navigating the Challenges and Opportunities in Immune-Related Adverse Event Management More broadly than this study, several contextual factors need to be considered before simply ...

Taking a pill is the easiest, least invasive way to take medicine, but unfortunately, not all drugs work that way. Now, Stanford scientists have found “an embarrassingly simple solution” that could ...